Back to Search
KARIE TULLY, PHARMD
PHARMD
Pharmacist
NPI: 1376916254Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
14984-40(WI)
Research & Publications (10)
First-year results of an obesity prevention program at The Dow Chemical Company.
PMID 19209033·J Occup Environ Med·2009
4-observational
Development of the Environmental Assessment Tool (EAT) to measure organizational physical and social support for worksite obesity prevention programs.
PMID 18301169·J Occup Environ Med·2008
4-observational
Using formative research to develop environmental and ecological interventions to address overweight and obesity.
PMID 18073340·Obesity (Silver Spring)·2007
8-other
Norepinephrine enables the induction of associative long-term potentiation at thalamo-amygdala synapses.
PMID 17709755·Proc Natl Acad Sci U S A·2007
7-preclinical
stathmin, a gene enriched in the amygdala, controls both learned and innate fear.
PMID 16286011·Cell·2005
4-observational
Chronic ethanol exposure induces an N-type calcium channel splice variant with altered channel kinetics.
PMID 15670827·FEBS Lett·2005
7-preclinical
Good environmental policy leads to good public health policy: a lesson from the grassroots.
PMID 15540407·Healthc Q·2004
8-other
Distinct intracellular calcium profiles following influx through N- versus L-type calcium channels: role of Ca2+-induced Ca2+ release.
PMID 14999048·J Neurophysiol·2004
4-observational
A plasticizer released from IV drip chambers elevates calcium levels in neurosecretory terminals.
PMID 11042090·Toxicol Appl Pharmacol·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2840 21ST PL S
LA CROSSE, WI 54601 - Phone
- (608) 784-6500
Quick Facts
- NPI
- 1376916254
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 10
Are you this provider?
Claim Your Profile